Chemours Launches Strategic Review of European Materials Business Amidst Declining Demand
On February 18, 2025, Chemours announced a strategic review of its Advanced Performance Materials (APM) business in Europe following the release of its 2024 financial results. This decision comes in response to a 5% decline in net sales, totaling $5.8 billion, primarily driven by a 4% drop in prices and changes in its investment portfolio.
The APM division, which provides products such as fluoropolymers, fluororubbers, and membranes, operates production facilities in Belgium and France. CEO Denise Dignam revealed that Chemours has written down some APM assets and postponed plans to expand Nafion ion exchange material production, crucial for hydrogen generation, due to lower-than-expected market demand projected until 2030.
In addition, Chemours will exit its Surface Protection Solutions (SPS) Capstone business, citing regulatory changes that have decreased demand. Production is set to conclude by the end of Q2 2025, pending local regulatory approvals.
Chemours continues to lead in sectors like thermal and specialty solutions, titanium technologies, and advanced performance materials, providing tailored solutions across various industries, including coatings, plastics, and electronics.
The company’s focus on strategic adjustments reflects its commitment to adapt to market changes while striving to maintain a competitive edge in the evolving materials landscape.
2026-09-22
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
-
U.S. Formally Publishes India PFA Trade Cases, Raising New Barriers for Fluoropolymer Supply
-
China’s New Food-Contact Standards Take Effect, Resetting Compliance for Coatings and Silicone Rubber
-
UK’s £350 Million Critical Chemicals Fund Enters Formal Review, Offering Up to 50% Support Per Project
-
WACKER’s 2025 Loss Reaches €805 Million as the PACE Cost-Cutting Plan Becomes the Key Variable for 2026
-
Sudden Turmoil in Middle East Shipping Routes: Multiple Carriers Announce Emergency Navigation and Surcharge Policies
-
US Pushes G20 to Reassess Trade with China, Raising New Risks for Chemical Exporters
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
FDA Lifts Administrative Stay, Restoring Red No. 3 Ban Timeline for Food and Ingested Drugs
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
Recommend Reading
-
US Tariff Pressure on Canada Raises Risks for North American Chemical Supply Chains
-
FDA Slows Two Natural Color Approvals, but the Additive Shift Is Still Moving
-
Thymol Gel Wins EPA Approval for Beekeepers
-
FSANZ Moves Toward Approval of Insect-Resistant Corn COR121
-
FDA Tightens the Solvent Side of Natural Color Production
-
Business Society’s Market Outlook for Fuel Oil 180CST on August 31, 2026: Volatile
-
Natural Rubber Market Trends Have Been Volatile and Consolidating Since July
-
Cost-side Support Boosts Polyester Staple Fiber Prices, Stopping the Decline and Rebounding
-
Strong Cost Support Drives Continued Strength in PTA Prices
-
Business Society’s Market Outlook for Maleic Anhydride on August 21, 2026: Volatile